The Presence of HER2 Exon 20 Insertion in Patients with Central Nervous System Metastases from Non-Small Lung Cancer—A Potential Application in Classification for Therapy
Abstract
Share and Cite
Nicoś, M.; Krawczyk, P.; Mlak, R.; Sawicki, M.; Jarosz, B.; Powrózek, T.; Milanowski, P.; Trojanowski, T.; Milanowski, J. The Presence of HER2 Exon 20 Insertion in Patients with Central Nervous System Metastases from Non-Small Lung Cancer—A Potential Application in Classification for Therapy. Adv. Respir. Med. 2013, 81, 294-297. https://doi.org/10.5603/ARM.34788
Nicoś M, Krawczyk P, Mlak R, Sawicki M, Jarosz B, Powrózek T, Milanowski P, Trojanowski T, Milanowski J. The Presence of HER2 Exon 20 Insertion in Patients with Central Nervous System Metastases from Non-Small Lung Cancer—A Potential Application in Classification for Therapy. Advances in Respiratory Medicine. 2013; 81(4):294-297. https://doi.org/10.5603/ARM.34788
Chicago/Turabian StyleNicoś, Marcin, Paweł Krawczyk, Radosław Mlak, Marek Sawicki, Bożena Jarosz, Tomasz Powrózek, Piotr Milanowski, Tomasz Trojanowski, and Janusz Milanowski. 2013. "The Presence of HER2 Exon 20 Insertion in Patients with Central Nervous System Metastases from Non-Small Lung Cancer—A Potential Application in Classification for Therapy" Advances in Respiratory Medicine 81, no. 4: 294-297. https://doi.org/10.5603/ARM.34788